Related Experiment Video

Updated: Aug 11, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

Lower airway disease caused by respiratory syncytial virus

R Aggarwal1

  • 1Department of Pediatric Critical Care, St. Mary's Medical Centre, Duluth, MN 55805, USA.

Indian Journal of Pediatrics
|April 20, 2000
PubMed

Insights

Respiratory syncytial virus (RSV) causes common respiratory infections in children. Severe RSV illness requires hospitalization, but supportive care, including oxygen and fluids, is the most effective treatment.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Virology

Background:

  • Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in infants and young children.
  • While most RSV infections are mild, certain infants with underlying conditions are at higher risk for severe disease and hospitalization.
  • The precise pathogenesis of RSV remains incompletely understood.

Purpose of the Study:

  • To review the current understanding of respiratory syncytial virus (RSV) infections in children.
  • To discuss the clinical presentation, risk factors for severe disease, and mortality associated with RSV.
  • To evaluate available treatment modalities and emphasize the role of supportive care.

Main Methods:

  • Literature review of studies on respiratory syncytial virus (RSV) epidemiology, pathogenesis, and treatment.
  • Analysis of reported mortality rates in healthy versus hospitalized children with RSV infection.
  • Evaluation of the efficacy of various treatment options, including bronchodilators, corticosteroids, and antiviral agents.

Main Results:

  • RSV is the most common cause of lower respiratory tract disease in young children, with varying mortality rates.
  • Infants with bronchopulmonary dysplasia, congenital heart disease, or prematurity face increased risks of severe RSV infection.
  • Existing treatments like bronchodilators and corticosteroids have shown limited proven benefits for RSV.

Conclusions:

  • Supportive care, including oxygen, fluid management, and vital sign monitoring, is the cornerstone of managing RSV infections.
  • The effectiveness of pharmacological interventions for RSV remains uncertain, highlighting the importance of supportive measures.
  • Further research into RSV pathogenesis and effective treatments is warranted to improve patient outcomes.

More Related Videos

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay09:14

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on: January 26, 2019

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

Related Concept Videos

Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...